generated: '2026-08-23'
method: searched
source: https://www.sail.bio/
plan_count: 0
plans: []
note: >-
  Not applicable rather than merely unpublished. Sail Biomedicines is a preclinical
  biopharmaceutical company with no commercial product and no API, so there is no plan, tier,
  quota, overage or per-tier limit to record. Searched the complete www.sail.bio sitemap
  (14 pages, 17 articles, 20 team-member pages) on 2026-08-23: there is no pricing page, no
  plans page, no developer page and no "contact sales" API motion anywhere on the site. The
  company's only published commercial terms are the July 2026 Johnson & Johnson collaboration
  ($785M up front, up to $140M in milestones, a $2.58B acquisition option), which is corporate
  deal structure, not API pricing, and is deliberately NOT recorded here.